Wholesale margins accounted for determining insurance prices for new drugs.

The Insurance Drug Price Specialist Council decided in the meeting on April 11 that the insurance prices for significantly innovated new drugs compared to existing drugs in terms of cost and efficacy would be accounted with wholesale margins in addition to the ex-factory prices at A7 countries plus VAT. The definition of "New drug" was referred to Article 2 Para. 12 of the Pharmaceutical Affair...